Detail
LncRNA Name | CCAT2 |
Synonyms | CCAT2, LINC00873, NCCP1 |
Region | GRCh38_8:127400399-127402150 Sequence |
Ensembl | ENSG00000280997 |
RefSeq | NR_109834 |
Circulating | ✘ |
Drug-resisitant | ✘ |
Prognostic | ✔ |
MiRNA | ✘ |
Variant | ✘ |
TF | ✔ |
Methylation | ✘ |
Cancer Name | hepatocellular carcinoma |
ICD-0-3 | C22.0 M8170/3 |
Methods | qPCR, RNAi, Cell migration and invasion assay etc. |
Sample | HCC tissues, cell lines (HepG2, SMMC772, MHCC97H and MIHA) |
Expression Pattern | up-regulated |
Function Description | CCAT2 was upregulated in HCC cell lines and cancerous tissues. The level of CCAT2 was positively associated with tumor-node-metastasis stages and vessel invasion. Moreover, we also found that knockdown of CCAT2 expression reduced cell migration and invasion in vitro. We further demonstrated that CCAT2 played a key role in enhancing the epithelial-mesenchymal transition (EMT) through the regulation of vimentin, E-cadherin and transcription factor snail2 expression. |
Pubmed ID | 28280353 |
Year | 2017 |
Title | Long non-coding RNA CCAT2 is associated with poor prognosis in hepatocellular carcinoma and promotes tumor metastasis by regulating Snail2-mediated epithelial-mesenchymal transition. |
External Links |
Links for CCAT2 | GenBank HGNC lncrnadb Noncode |
Links for hepatocellular carcinoma | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.